Tirzep Injection 7.5 mg/0.5 ml contains Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is indicated for the management of type 2 diabetes mellitus (T2DM) in adults. Tirzepatide helps control blood sugar by stimulating insulin secretion in response to elevated glucose levels, reducing glucagon release, slowing gastric emptying, and decreasing appetite.

This intermediate dose is typically used after initial titration from lower doses (2.5 mg or 5 mg) to optimize glycemic control while minimizing gastrointestinal side effects. It also provides benefits in weight management, making it a versatile option in diabetes care.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirzep Injection is indicated for:

• Adults with type 2 diabetes mellitus requiring better glycemic control
• Adjunct therapy for patients not adequately managed with diet and exercise
• Combination therapy with oral antihyperglycemic agents if needed
• Patients aiming for metabolic benefits including weight reduction

Mechanism of Action

Tirzepatide acts through dual receptor agonism:

1. GIP receptor activation: Enhances insulin secretion in a glucose-dependent manner.
2. GLP-1 receptor activation: Suppresses glucagon release, slows gastric emptying, and reduces appetite.

Together, these actions lead to improved fasting and postprandial blood glucose levels, reduced HbA1c, and potential weight loss.

Dosage and Administration

• Administered subcutaneously once weekly.
• Typical dose escalation: Start at 2.5 mg, increase to 5 mg, and then to 7.5 mg under medical supervision.
• Inject into the abdomen, thigh, or upper arm; rotate injection sites to prevent local reactions.
• Do not mix with other injectable medications or insulin.
• Adhere strictly to the prescribed schedule to maintain stable glycemic control.

Benefits

• Effective reduction in HbA1c for type 2 diabetes
• Supports weight management as part of diabetes care
• Convenient once-weekly dosing improves adherence
• Reduces fasting and postprandial glucose levels
• Dual GIP/GLP-1 mechanism provides superior metabolic control compared to single-agent therapy

Side Effects

Common side effects:

• Nausea and vomiting
• Diarrhea or constipation
• Injection site reactions (redness, swelling, or itching)
• Decreased appetite
• Mild headache or fatigue

Serious but rare side effects:

• Hypoglycemia, especially when used with insulin or sulfonylureas
• Pancreatitis (persistent severe abdominal pain)
• Allergic reactions, including anaphylaxis
• Thyroid C-cell tumors (rare; contraindicated in patients with a history of medullary thyroid carcinoma)

Seek immediate medical attention if severe reactions or pancreatitis symptoms occur.

Precautions and Warnings

• Not indicated for type 1 diabetes or diabetic ketoacidosis.
• Use caution in patients with a history of pancreatitis or severe gastrointestinal disease.
• Pregnancy and breastfeeding use only under medical supervision.
• Regular blood glucose monitoring is essential, particularly with combination therapy.
• Caution in patients with severe renal or hepatic impairment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirzep Injection may interact with:

• Other antidiabetic medications (increased risk of hypoglycemia)
• Oral drugs with narrow therapeutic ranges (due to delayed gastric emptying)
• Medications affecting gastrointestinal motility

Always inform your healthcare provider of all medications and supplements being taken.

Storage

• Store in a refrigerator at 2–8°C; do not freeze
• Protect from light and heat
• Keep out of reach of children
• Do not use after expiration date
• Follow package instructions for usage period after opening.